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Introduction
The Dogue de Bordeaux (DdB) is a large brachycephalic breed of dog, originating in France. The population and cardiac pathology of DdB in the United A C C E P T E D M A N U S C R I P T Kingdom (UK) has not been well described; however, anecdotal reports suggest that atrial fibrillation (AF) is prevalent in this breed and a recent study suggested that the breed may have a high incidence of sudden and unexpected death (McAulay et al., 2018) . The DdB is affected by a range of cardiac conditions, including subaortic stenosis (SAS), tricuspid dysplasia and dilated cardiomyopathy (DCM) (Borgarelli et al., 2006; Höllmer et al., 2008; Martin et al., 2009; Oliveira et al., 2011; Ohad et al., 2013) . A breed predisposition to supraventricular tachyarrhythmia has been suggested (Locatelli et al., 2011) . In a study by Ohad et al. (2013) , all DdB diagnosed with tricuspid dysplasia had AF.
Atrial fibrillation has a complex pathophysiology, whereby functional and structural mechanisms promote electrical re-entry (Brundel et al., 2005) . Atrial fibrillation is frequently associated with heart disease; increased atrial dimensions, inflammation, fibrosis, alterations in autonomic tone and ion channel expression promote development of AF. Large breeds of dog might be predisposed to AF because their atrial dimensions provide the critical atrial mass required to support wavelet reentry (Moore and Spear, 1987; Guglielmini et al., 2000) . Atrial fibrillation in the absence of structural heart disease has been described as 'lone' AF (Menaut et al., 2005) . Frequent arrhythmia, including AF, can promote cardiac chamber remodelling and a dilated cardiomyopathy (DCM) phenotype, designated tachycardia-induced cardiomyopathy (Shinbane et al., 1997) .
Since AF can be a cause, or consequence, of structural or functional disease, clarifying the association of AF with phenotype may be helpful in defining the underlying disease process. This study sought to describe the phenotype of DdB within A C C E P T E D M A N U S C R I P T a cardiac referral population, specifically with reference to the prevalence and associated features of AF. We hypothesised that AF is the predominant arrhythmia in DdBs undergoing cardiac investigation and that AF reflects a primary arrhythmia, rather than consequence of structural heart disease. We hypothesised that AF would occur in some dogs in the absence of cardiac chamber remodelling. 
Materials and methods
Study group
Echocardiography
Echocardiographic examinations were performed as described by Thomas et al. (1993) , using a Vivid 7 (GE Healthcare), with simultaneous ECG recording, and reviewed and measured using EchoPAC Clinical Workstation Software (GE Healthcare). Left ventricular measurements were obtained in M-mode using the leading edge to leading edge method (Sahn et al., 1978) . The mean of three measurements for dogs in sinus rhythm and five measurements for dogs with arrhythmia were recorded for each variable. Left ventricular systolic and diastolic measurements were normalised to body weight (Cornell et al., 2004) . Normalised left ventricular systolic diameter The pre-ejection period to ejection time ratio (PEP:ET) was calculated from Doppler interrogation of aortic flow obtained from the left apical five chamber or subcostal view (de Madron, 2015) . Left atrial diameter was indexed to aortic diameter (LA:Ao) (Hansson et al., 2002) . Right sided dilatation was defined as right ventricular diastolic dimensions exceeding 50% of the diameter of the left ventricle or right atrial dimensions that were subjectively larger than the left atrium in any view (Bright et al., 2005; Menaut et al., 2005; Palermo et al., 2011) . If dogs exhibited left ventricular dilatation, right ventricular dilatation was assessed subjectively on the basis of clinical experience.
Pulmonary hypertension (systolic) was diagnosed when Doppler-derived tricuspid regurgitation velocity exceeded 3.1 m/s (> 38 mmHg) (Stepien, 2009 ) and was classified as mild (< 50 mmHg), moderate (≥ 50 mmHg to <80 mmHg) or severe (≥ 80 mmHg). The aortic valve, outflow tract and Doppler profile were assessed; velocities > 2.5 m/s were considered to be consistent with SAS (Bussadori et al., 2000; Höllmer et al., 2008) . Pulmonic valve morphology was assessed according to Bussadori et al. (2000) ; pulmonic stenosis was defined by pulmonic velocities > 2.25 m/s.
Electrocardiography
ECG data were collected from the original ECG, Holter, echocardiographic (Santilli et al., 2008) . Atrial fibrillation was diagnosed when QRS complexes occurred without periodicity in the absence of P waves or flutter waves 
Statistical analysis
After initial assessment of the whole population, dogs with congenital heart disease, cardiac masses and non-cardiac neoplasia were excluded from further assessment, and the clinical, echocardiographic and ECG findings of the remaining subset (non-CHDN) were explored further.
Statistical analysis was performed using Prism 6 (GraphPad Software). Data
were assessed for normality visually and using the D'Agostino and Pearson omnibus normality test. Normally distributed data were expressed as mean ± standard deviation 
Results
The study included 64 DdB ( (Table 2 ). Holter data were available for 13/15 (86.7%) dogs with ventricular arrhythmia, with a median of 105 (IQR 5-543) VPCs/24 h. In dogs with isolated VPCs on Holter, 6/7 (85.7%) had less than 100 VPCs/24 h.
In the subset of 34 non-CHDN dogs; 19 (56%) had AF, 12 (35%) had sinus rhythm and three (9%) had SVT, which was paroxysmal in 2/3 dogs (median SVT 240 bpm) ( Fig. 2 ; Table 3 ). The three dogs with SVT were younger than the 31 dogs with other arrhythmias (P = 0.027; Fig. 3 ). Non-CHDN dogs with AF (n = 19) had a median Pulmonary hypertension was identified in six non-CHDN dogs, four with mild and two with moderate severity; the latter two had AF and right sided atrial/ventricular dilatation. The prevalence of collapse did not differ between sinus, SVT or AF rhythm (P = 0.958).
Discussion
In this study supraventricular arrhythmias were detected in a high proportion of DdBs assessed by veterinary cardiologists at two UK referral hospitals. Atrial fibrillation was documented in 39% of all DdB. In the non-CHDN subset (DdB without congenital heart disease or neoplasia), the prevalence of atrial fibrillation was 56%. A previous Italian study reported AF in 3/39 (7.7%) apparently healthy DdB (Locatelli et , 2011) . Since dogs in our study were drawn from a cardiology referral population with a high prevalence of auscultated arrhythmia and exercise intolerance, it is unsurprising that the prevalence of AF in our study was higher than in a general population; however, our findings support the hypothesis that AF is the predominant arrhythmia in DdB undergoing cardiac investigation in the UK.
In the non-CHDN subset, 3/19 DdB with AF had a structurally normal heart.
Atrial fibrillation in the absence of structural cardiac disease has been described as 'lone' AF (Takemura et al., 2002; Menaut et al., 2005) . However, the term 'lone' AF has been questioned because of inconsistent definition and improved ability to detect predispositions to AF (Wyse et al., 2014) . Low heart rates have been reported in dogs with AF without structural or functional heart disease (Menaut et al., 2005) . In our study, only one non-CHDN dog with AF without structural or functional disease had a heart rate < 160 bpm on presentation. Whether fast AF rates at presentation reflect more advanced underlying disease, stress or a breed propensity to tachyarrhythmia remains unclear.
Nine of 34 (26%) non-CHDN DdB had increased left heart dimensions and systolic dysfunction, consistent with a dilated cardiomyopathy (DCM) phenotype, and 5/9 (55%) of these dogs had AF. DCM has been characterised by systolic and diastolic dysfunction, and variable ventricular dilatation (Kittleson, 1998; Tidholm et al., 2001) , which can precipitate valvular incompetence, atrial dilatation and arrhythmias, particularly AF (Dukes-McEwan et al., 2003) . The prevalence of AF in a previous retrospective study of DCM was 45%, with a high prevalence in the Irish wolfhound, Great Dane and Newfoundland (Tidholm and Jönsson, 1996; Vollmar, 2000; , 2001a; Martin et al., 2009) . DCM has been reported previously in the DdB; however, the inconsistent relationship of AF to the DCM phenotype in this population suggests that left ventricular dilatation does not always precede development of AF.
Atrial fibrillation occurs frequently in the Irish wolfhound, with and without DCM, and is reported in up to 87.6% of Irish wolfhounds with a diagnosis of DCM (Vollmar, 2000) . Studies in Irish wolfhounds support an association between AF and DCM, which develops in the majority of dogs with AF (Simpson et al., 2016) . Whether DCM in the Irish wolfhound reflects a primary cardiomyopathy, atrial dysfunction or sustained tachycardia is unclear (Brownlie and Cobb, 1999) . Familial DCM associated with early AF has been reported in human beings (Sébillon et al., 2003) , but sustained tachyarrhythmia, including AF, may result in biventricular systolic dysfunction and eccentric dilatation (Wilson et al., 1987; Shinbane et al., 1997; Schoonderwoerd et al., 2001; Dukes-McEwan et al., 2003) .
A feature of DdBs in this study was the high frequency of right sided atrial or ventricular dilatation, which were evident in 27/64 (42.1%) of all dogs and over half of non-CHDN dogs in the absence of severe pulmonary hypertension. In a retrospective study of DCM in the Irish wolfhound, predominantly right sided dilatation was reported in 5.4% dogs and right sided changes only in 4.2% of dogs (Vollmar, 2000) . Atrial fibrillation has been described previously in DdBs with tricuspid dysplasia (Ohad et al., 2013) . Tricuspid dysplasia in dogs has been defined by echocardiographic characteristics including leaflet thickening, tethering and valvular insufficiency, as assessed by right atrial dilatation and regurgitant jet area (Bonagura et al., 1999; Oyama and Sisson, 2001; Ohad et al., 2013) . In human beings, functional tricuspid insufficiency due to annular distortion and alterations in papillary muscle geometry has been reported to be secondary to right and left ventricular dilatation, systolic dysfunction and respiratory phase (Rogers and Bolling, 2009; Topilsky et al., 2014; Tornos Mas et al., 2015) . The assessment of tricuspid insufficiency by regurgitant jet area has been discouraged because of technical limitations (Lancellotti et al., 2010) .
Alterations in papillary muscle geometry result in the echocardiographic appearance of leaflet tethering and reduced valvular coaptation (Spinner et al., 2012) . In human beings with chronic AF in the absence of organic heart disease, the development and severity of tricuspid regurgitation has been associated with AF type and duration (Najib et al., 2011; Park et al., 2015) . In view of the unknown influence of these factors in dogs, we could not confidently define normal or dysplastic tricuspid morphology and only described right sided dilatation. Although many DdBs with AF displayed right sided atrial or ventricular dilatation and systolic dysfunction, no non-CHDN dogs had right sided dilatation without supraventricular arrhythmia or systolic dysfunction (Fig. 4) .
This observation suggests that right sided dilatation might reflect cardiac dysfunction rather than primary valvular disease in some DdBs.
Five dogs in our study had supraventricular tachycardia (one persistent and four paroxysmal). Although the number of dogs with SVT was small, the three non-CHDN dogs with SVT were younger than dogs with sinus rhythm and AF. In dogs, SVT has been associated with structural heart disease and systemic disease (Kittleson, 1998; Finster et al., 2008) . Atrial pathology predisposing to supraventricular arrhythmia has been described in association with ARVC (Fox et al., 2000; Basso et al., 2004; Mano et al., 2013; Vila et al., 2017) , and SVT has been reported in Boxers with ARVC (Baumwart et al., 2005) . In human beings, paroxysmal SVT is closely associated with paroxysmal AF and it has been suggested that SVT might predispose to AF development because of atrial stretch, reduced atrial refractoriness and vagal activation during tachycardia (Chang et al., 2008) . Focal atrial tachycardia (FAT) was reported in two DdB in a series of 16 dogs diagnosed with FAT by electrophysiological study (Santilli et al., 2010) . Seven of these dogs had a surface ECG diagnosis of AF. The and 24% of DdBs in screened and referral populations, respectively (Höllmer et al., 2008; Ohad et al., 2013) .
Our study has several limitations, inherent in any retrospective studies. The inclusion of dogs with concurrent disease might influence heart rate and rhythm, and no account was taken of the potential influence of medications on heart rate or cardiac dimensions. We elected to use normalised left ventricular M-mode measurements and defined values exceeding 95% CI predicted values to categorise left ventricular dimensions and systolic function because of the availability of these images. There are acknowledged limitations of M-mode measurements and it would have been preferable to have assessed left ventricular dimensions and function by calculation of end systolic volume index using Simpson's method of discs (Lang et al., 2005; Tidholm et al., 2010) . The use of 95% CI predicted values determined by the Cornell method may be insensitive because of the wide prediction intervals. Quantitative evaluation of right
sided dimensions would have been preferable; however, the retrospective nature of this study meant that images optimised for right sided evaluation were rarely available. Our inability to more clearly define the presence and magnitude of right sided dilatation is a substantial limitation.
Holter ECG was inconsistently available and this may have limited our ability to obtain representative heart rates. Some cases presenting with sinus rhythm may have had unidentified paroxysmal supraventricular arrhythmia, predisposing to systolic dysfunction or chamber dilatation; our definition of SVT may include some dogs with sinus tachycardia. No cases had an electrophysiological study to clarify the mechanism of arrhythmia, so some rhythms may have been misclassified on surface ECG.
Conclusions
In this UK referral population of DdB, cardiac masses and subaortic stenosis were relatively frequent. The prevalence of supraventricular arrhythmia, specifically fast AF with ventricular response rate exceeding 160 bpm, was high. Atrial fibrillation was associated with cardiac chamber dilatation in the majority of dogs. Most dogs with atrial fibrillation had right sided dilatation and systolic dysfunction; however, this was inconstantly associated with left ventricular dilatation or a DCM phenotype. After excluding dogs with congenital heart disease and neoplasia, no remaining dogs had right sided dilatation in the absence of supraventricular arrhythmia or systolic dysfunction. In view of the subjective classification of right sided dilatation in this retrospective study, any inferences drawn from these observations should be viewed cautiously. Potential aetiologies include primary cardiomyopathy with right sided predilection and/or predisposition to supraventricular arrhythmia with cardiac
remodelling secondary to tachycardia-induced cardiomyopathy. Since some cardiomyopathies may be associated with a propensity for supraventricular arrhythmia, these mechanisms may not be mutually exclusive. Serial echocardiographic and Holter studies may help to clarify if supraventricular arrhythmia typically develops as a consequence of chamber dilatation, or if it precedes cardiac chamber remodelling in the DdB, and whether the findings from this small study are representative of the wider DdB population.
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Figure legends DdB undergoing cardiac evaluation with available echocardiographic and electrocardiographic ± Holter data n = 64
DdB with non-cardiac neoplasia n = 6
DdB with objectively definable congenital disease other than SAS n = 5
DdB with cardiac masses n = 7
DdB with no congenital heart disease, cardiac mass or noncardiac neoplasia (non-CHDN) n = 34
DdB with SAS n = 12 Normally distributed data expressed as mean ± standard deviation (SD). A C C E P T E D M A N U S C R I P T a Within each row, data that were not significantly different between the two indicated groups.
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